NEW YORK (GenomeWeb) – In a filing with the US Securities and Exchange Commission this week, Foundation Medicine said it is planning to expand its offices in Cambridge, Massachusetts, and will take over a lease for approximately 53,455 square feet of office and laboratory space currently occupied by Bluebird Bio. The company has also extended its lease through April 30, 2024. In its SEC filing, Foundation noted that the monthly rent on the space will start at $418,308.53 in May 2017, and will go up incrementally until it reaches $833,675.37 per month in April 2024.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.